Long-term follow-up of patients with obstructive hypertrophic cardiomyopathy treated with dual-chamber pacing

Angelique Megevand; Jodie Ingles; David R Richmond; Christopher Semsarian

doi:10.1016/j.amjcard.2004.12.045

Long-term follow-up of patients with obstructive hypertrophic cardiomyopathy treated with dual-chamber pacing

Am J Cardiol. 2005 Apr 15;95(8):991-3. doi: 10.1016/j.amjcard.2004.12.045.

Authors

Angelique Megevand¹, Jodie Ingles, David R Richmond, Christopher Semsarian

Affiliation

¹ Agnes Ginges Centre for Molecular Cardiology, Centenary Institute, Department of Cardiology, Royal Prince Alfred Hospital, Sydney, Australia.

PMID: 15820173
DOI: 10.1016/j.amjcard.2004.12.045

Abstract

In this study, patients with obstructive hypertrophic cardiomyopathy (HC) were treated with dual-chamber pacemaker therapy. Long-term follow-up analysis showed that dual-chamber pacemaker therapy in selected patients resulted in a significant reduction in symptoms and in the left ventricular outflow tract gradient, which was maintained up to 10 years after implantation. Dual-chamber pacing is of potential long-term benefit in selected groups of patients with obstructive HC.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adult
Cardiomyopathy, Hypertrophic / pathology*
Cardiomyopathy, Hypertrophic / therapy*
Female
Follow-Up Studies
Humans
Male
Middle Aged
Pacemaker, Artificial*
Treatment Outcome
Ventricular Function, Left